ANDA 65015, held by Ranbaxy Labs Ltd. Cefadroxil/Cefadroxil Hemihydrate.
As of Nov 16, 2026, ANDA 65015 (Cefadroxil), held by Ranbaxy Labs Ltd, was first approved by FDA on Jun 22, 1999, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 22, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| CefadroxilEQ 500MG BASE ยท capsule;oral | Cefadroxil/Cefadroxil Hemihydrate | Discontinued |
| Mar 22, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Mar 22, 2002 | Supplement 4Labeling | Approved | None posted |
| Dec 21, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Dec 21, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Jun 22, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters